Basepoint Wealth’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65 Sell
2
-124
-98% -$5.54K ﹤0.01% 626
2026
Q1
$6.09K Hold
126
﹤0.01% 463
2025
Q4
$6.13K Buy
+126
New +$6.25K ﹤0.01% 441

Other funds holding SNY

Basepoint Wealth's SNY Position: Q2 2026 in Review

Basepoint Wealth reduced its Sanofi (SNY) stake by 98% in Q2 2026, selling an estimated $5.54K and leaving 2 shares worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Basepoint Wealth first reported a position in SNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.13K in Q4 2025. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Basepoint Wealth held 2 shares of Sanofi worth $65 as of Q2 2026.
  • Basepoint Wealth sold 124 Sanofi shares in Q2 2026, an estimated $5.54K.
  • Sanofi made up ﹤0.01% of Basepoint Wealth's portfolio in Q2 2026, its #626 holding.
  • Basepoint Wealth first reported a position in Sanofi in Q4 2025 and has held it in 3 quarters since.
  • Basepoint Wealth's Sanofi position peaked at $6.13K in Q4 2025.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Basepoint Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.